Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,994
Total Claims
$1.9M
Drug Cost
2,416
Beneficiaries
$802
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-32%
Cost per patient vs peers
$802 vs $1,174 avg
+158%
Brand preference vs peers
22.9% vs 8.9% avg
Brand vs Generic
Brand: 2,361 claims · $1.7M
Generic: 7,957 claims · $170K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 198 | $263K |
| Dulaglutide | 111 | $157K |
| Semaglutide | 118 | $145K |
| Apixaban | 177 | $137K |
| Semaglutide | 70 | $98K |
| Sitagliptin Phosphate | 77 | $91K |
| Dapagliflozin Propanediol | 58 | $69K |
| Rivaroxaban | 44 | $62K |
| Insulin Glargine,hum.Rec.Anlog | 158 | $57K |
| Budesonide/Formoterol Fumarate | 119 | $51K |
| Fluticasone Propion/Salmeterol | 86 | $44K |
| Sacubitril/Valsartan | 28 | $33K |
| Diclofenac Sodium | 226 | $32K |
| Umeclidinium Bromide | 60 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $28K |
Prescribing Profile
Patient Profile
73
Avg Age
70%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data